Quick Takeaways
- This page summarizes Ramesh Kumar's Form 4 filing for Ocugen, Inc. (OCGN).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 20 Jul 2022, 16:19.
Ramesh Kumar - 18 Jul 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)
- Role
- Director
- Signature
- /s/ Ramesh Kumar by Shankar Musunuri, his attorney-in-fact
- Issuer symbol
- OCGN
- Transactions as of
- 18 Jul 2022
- Net transactions value
- -$15,450
- Form type
- 4
- Filing time
- 20 Jul 2022, 16:19:18 UTC
- Previous filing
- 08 Jun 2022
- Next filing
- 07 Oct 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Ramesh Kumar filed Form 4 for Ocugen, Inc. (OCGN) on 20 Jul 2022."
What Changed
- Previous filing in this sequence was filed on 08 Jun 2022.
- Current net transaction value: -$15,450.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OCGN | Common Stock | Options Exercise | $3,825 | +7,500 | $0.5100 | 7,500 | 18 Jul 2022 | Direct | ||
| transaction | OCGN | Common Stock | Sale | $19,275 | -7,500 | -100% | $2.57* | 0 | 18 Jul 2022 | Direct | F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OCGN | Option (Right to Buy) | Options Exercise | $0 | +7,500 | +500% | $0.000000 | 9,000 | 18 Jul 2022 | Common Stock | 7,500 | $0.5100 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.56 to $2.61. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. |